If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
124.00    -0.50 (-0.40%)
Bid:
122.00
Ask:
126.00
Spread: 4.00 (3.279%)
Market Cap: £41.91m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Issue of Equity

26 Mar 2024 07:00

RNS Number : 2292I
Onward Opportunities Limited
26 March 2024
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

26 March 2024

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Issue of Equity

 

Subscription to raise approximately £1.66 million

 

Onward Opportunities Limited, the UK smaller company focussed investment company, is pleased to announce that in response to investor demand it has raised gross proceeds of approximately £1.66 million by way of a direct subscription (the "Subscription"), by new and existing investors, for 1,513,240 new ordinary shares (the "Subscription Shares") at a price of 110 pence per new ordinary share (the "Subscription Price"). The Subscription Price represents a premium of 2.0 per cent. to the Company's unaudited net asset value per ordinary share as at 29 February 2024 of 107.8 pence per existing ordinary share.

 

The Board and Portfolio Manager continue to believe that there are compelling structural factors underpinning the investment strategy and that prevailing market conditions create an environment in which the Portfolio Manager has the ability to generate aggregated portfolio returns in excess of 15 per cent. per annum over the long term. The net proceeds of the Subscription of approximately £1.61 million will provide the Company with additional resources with which to pursue its stated investing policy.

 

Onward Opportunities was launched on 30 March 2023 and was the first investment company to list on AIM since November 2021. The Company recently reported its Q4 Factsheet for the period to 31 December 2023, noting a rewarding first financial year of investment performance (NAV growth) for the Company of 11.3% since inception.

 

Laurence Hulse, Lead Fund Manager of Onward Opportunities Limited, commented: "We are establishing encouraging early signs that Onward Opportunities has a strategy to generate absolute returns for our shareholders. We are delighted to have been able to raise additional capital for the second time in twelve months. This will enable the company to capitalise on an exciting pipeline of opportunities and will be deployed into additional investments for the portfolio."

 

Application has been made for the Subscription Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 27 March 2024 and the Subscription Shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares.

 

On Admission, the Company will have a total of 17,540,530 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 17,540,530 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Related Party Participation in the Subscription

 

Dowgate Wealth Limited (the "Portfolio Manager"), the Company's Portfolio Manager and a Substantial Shareholder of the Company, and its affiliates have subscribed for 696,470 Subscription Shares. As a result, and on Admission, the members of the Concert Party in the Company will collectively hold an aggregate of 9,719,826 ordinary shares in the Company, representing 55.4 per cent. of the Company's enlarged issued ordinary share capital.

 

The directors of the Company, having consulted with the Company's nominated adviser, consider that the terms of the participation of the Portfolio Manager in the Subscription are fair and reasonable insofar as shareholders are concerned.

 

FOR FURTHER ENQUIRIES:

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Camilla Hume / Dan Hodkinson / Hamish Waller

Michael Johnson / George Budd (Sales)

 

Tel: +44 (0) 207 220 0500

Dowgate Capital Limited (Joint Broker)

Russell Cook / Nicholas Chambers

 

Tel: +44 (0)20 3903 7715

 

To find out more, please visit: www.onwardopportunities.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEVELFLZXLBBBL
Date   Source Headline
9th Jul 20261:50 pmRNSHolding(s) in Company
9th Jul 202612:38 pmRNSNet Asset Value(s)
9th Jul 20267:00 amRNSIssue of Equity
8th Jul 20267:00 amRNSPublication of June 2026 Factsheet
3rd Jul 20267:00 amRNSIssue of Equity
2nd Jul 202612:33 pmRNSNet Asset Value(s)
1st Jul 20262:41 pmRNSNet Asset Value(s)
1st Jul 20267:00 amRNSTotal Voting Rights
29th Jun 20267:00 amRNSIssue of Equity
26th Jun 20267:00 amRNSIssue of Equity
25th Jun 20261:04 pmRNSNet Asset Value(s)
18th Jun 202612:06 pmRNSNet Asset Value(s)
17th Jun 202611:20 amRNSDirector/PDMR Shareholding
11th Jun 202612:52 pmRNSNet Asset Value(s)
4th Jun 202611:57 amRNSNet Asset Value(s)
2nd Jun 202612:26 pmRNSPublication of May 2026 Factsheet
1st Jun 202612:03 pmRNSNet Asset Value(s)
28th May 202612:12 pmRNSNet Asset Value(s)
21st May 202611:34 amRNSNet Asset Value(s)
14th May 202612:17 pmRNSNet Asset Value(s)
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20264:39 pmRNSPurchase of Shares by the Portfolio Manager
7th May 20263:51 pmRNSPublication of April 2026 Factsheet - Replacement
7th May 202612:44 pmRNSPublication of April 2026 Factsheet
7th May 202611:50 amRNSNet Asset Value(s)
1st May 202611:31 amRNSNet Asset Value(s)
1st May 20267:01 amRNSTotal Voting Rights
1st May 20267:00 amRNSIssue of Equity
30th Apr 202611:54 amRNSNet Asset Value(s)
24th Apr 20267:00 amRNSIssue of Equity
23rd Apr 202611:54 amRNSNet Asset Value(s)
21st Apr 20262:12 pmRNSHolding(s) in Company
21st Apr 202610:24 amRNSPublication of Q1 2026 Factsheet
20th Apr 20269:05 amRNSBlock Admission Application
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20261:10 pmRNSNet Asset Value(s)
16th Apr 20268:00 amRNSReadmission - Onward Opportunities Limited
16th Apr 20267:00 amRNSAdmission to Main Market and AIM Cancellation
15th Apr 20269:29 amRNSResult of AGM
14th Apr 20262:46 pmRNSPurchase of Shares by Portfolio Manager
13th Apr 202612:19 pmRNSPublication of a Prospectus
9th Apr 20265:30 pmRNSOnward Opportunities
1st Apr 20264:13 pmRNSNet Asset Value(s)
26th Mar 202611:25 amRNSUpdate re Main Market Listing and Notice of AGM
2nd Mar 20264:56 pmRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSIntended Main Market Listing
2nd Mar 20267:00 amRNSAnnual Results
5th Feb 20268:39 amRNSChange of Adviser
2nd Feb 20264:45 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.